Six-step continuous flow synthesis of diclofenac sodium via cascade etherification/smiles rearrangement strategy: tackling the issues of batch processing
Six-step continuous flow synthesis of diclofenac sodium via cascade etherification/smiles rearrangement strategy: tackling the issues of batch processing
复制标题
通过级联醚化/smile重排策略六步连续流程合成双氯芬酸钠:解决批量处理问题
DOI:
10.1002/chem.202201420
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Fener Chen
中科院分区:
文献类型:
--
作者:
Lulu Wang;Minjie Liu;Meifen Jiang;Li Wan;Weijian Li;Dang Cheng;Fener Chen
Diclofenac sodium is a widely used nonsteroidal anti‐inflammatory drug (NSAID) as over‐the‐counter (OTC) medication for the treatment of inflammatory diseases. Herein, the development of an intensified six‐step continuous flow synthesis of diclofenac sodium from commercially available aniline and chloroacetic acid is described. A challenging and unprecedented etherification/Smiles rearrangement cascade of 2‐chloro‐N‐phenylacetamide and 2,6‐dichlorophenol into hydroxyacetyldiphenylamine operated with the precise control of reaction conditions in continuous flow was realized as the key step in this multistep synthetic chemistry. The undesired amide hydrolysis in Smiles rearrangement was addressed and the extra installation ofN‐chloroacetyl group in current industrial batch mode was avoided. Diclofenac sodium was obtained in 63 % isolated yield with an average yield of above 90 % for each step in a total residence time of 205 min.